Clinical Microbiology Newsletter
Volume 31, Issue 17 , Pages 129-136, 1 September 2009

The Impact of Clinical Laboratory Improvement Advisory Committee Recommendations on Microbiology Laboratories

  • Nancy L. Anderson, M.M.Sc.

      Affiliations

    • Centers for Disease Control and Prevention, Atlanta, Georgia
    • Corresponding Author InformationCorresponding author: Nancy L. Anderson, M.M.Sc., Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mailstop F-11, Atlanta, GA 30329-4018. Tel.: 404-498-2741. Fax: 404-498-2219
  • ,
  • Diane C. Bosse, M.S.
  • ,
  • Alice S. Weissfeld, Ph.D., D(ABMM), F(AAM)

      Affiliations

    • Microbiology Specialists Incorporated, Houston, Texas

Abstract 

The Clinical Laboratory Improvement Advisory Committee (CLIAC) was mandated by the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and established in 1992 to provide advice to the Department of Health and Human Services on regulation of laboratory testing and improving laboratory quality. Since then, CLIAC has met regularly and recommended regulatory changes to CLIA, provided input on good laboratory practices, and discussed critical issues related to clinical and public health testing, the laboratory workforce, and laboratory systems research. The Committee has been effective in driving changes to microbiology quality control, which have led to a decreased burden and lower laboratory costs without sacrificing quality. The issues CLIAC addresses are complex and sometimes controversial, yet members have said their time on the Committee is worthwhile and that CLIAC has a positive influence on laboratory medicine. This Committee will remain a vital resource for providing guidance as laboratory testing continues to evolve.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0196-4399(09)00039-7

doi:10.1016/j.clinmicnews.2009.08.001

Clinical Microbiology Newsletter
Volume 31, Issue 17 , Pages 129-136, 1 September 2009